07.07.2011 • NewsDowDow Chemicalcooperation

Dow Chemical, Ube Form Electrolyte Joint Venture

Dow Chemical has formed a joint venture with Japan's Ube Industries Ltd to produce electrolytes for lithium ion batteries, the companies said on Wednesday.

The joint venture, Advanced Electrolyte Technologies LLC, will build a plant near Dow's Midland, Michigan, manufacturing complex in 2012 to produce electrolytes, which act as an electrical conduit between a battery's cathode and anode.

Electrolytes produced at the plant will be superior to others on the market and will help improve battery efficiency, David Klanecky, a senior business director at Dow's energy materials division, told Reuters.

Each company will have a 50% stake in the venture. Dow declined to provide specifics of its initial investment.

Midland-based Dow expects the market for lithium ion battery materials to reach $8 billion by 2020, up from $400 million today.

There are no estimates on the number of jobs the venture will create, and revenue estimates are not being disclosed, a Dow spokesman said.
Dow said the new plant would be able to produce 5,000 to 10,000 tons of electrolytes per year.

The joint venture is considering building plants in China and Europe within five years, Dow said.

The recent Japanese earthquake and tsunami are not likely to affect the joint venture, the Dow spokesman said.

 

 

Company

The Dow Chemical Company

100 Larkin Center
48674 Midland

Company contact







Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.